mental disability. Unspecified intellectual disabilities
Conditions
Interventions
Intervention 1: Intervention group:2 mcg/kg/hr dexmedetomidine will be administered via infusion until the end of general anesthesia. Intervention 2: Control group: 50% N2O / 50% O2 along with 100 mcg
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 50 Years
Inclusion criteria
Inclusion criteria: mentally disabled without systemic diseases or physical disabilities need dental treatment under general aneasthesia
Exclusion criteria
Exclusion criteria: unwilling to participate in the study using tranquillizers, anticonvulsive, antidepressants, antipsychotic drugs allergic to soy or eggs hepatic diseases Morbidly obese (BMI=40)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Agitation in recovery. Timepoint: once. Method of measurement: Richmond Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Once every 15 minutes during anesthesia. Method of measurement: pulsometer.;Anesthesia time. Timepoint: Once during anesthesia. Method of measurement: clock.;Analgesia need in recovery. Timepoint: Once during the patient's recovery. Method of measurement: recording.;Recovery time. Timepoint: Once during the patient's recovery. Method of measurement: clock.;Systolic blood pressure. Timepoint: Once every 15 minutes during anesthesia. Method of measurement: pressure cuff. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Naser Kaviani
Esfahan University of Medical Sciences
Outcome results
None listed